文献速递姑息放疗与转移瘤

骨转移患者立体定向体部放疗与传统放疗后的生活质量比较

Quality of Life After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2022-01-10

该研究为PRESENT试验的预设二次分析,基于2期随机对照VERTICAL试验(NCT02364115)纳入的110例患者,1:1随机接受传统放疗(cRT)或立体定向体部放疗(SBRT)。结果显示两组患者报告的生活质量各领域随时间改善且组间总体相当,但cRT组在功能干扰和心理社会方面的改善优于SBRT组。

要点

  • 两组患者报告的总体生活质量、躯体功能、情绪功能等随时间改善且组间相当。
  • cRT组在12周时功能干扰评分改善优于SBRT组(25.5 vs 14.1分,ES=0.49,P=.04)。
  • cRT组在8周时心理社会方面评分改善优于SBRT组(12.2 vs 7.3分,ES=0.56,P=.04)。

核心结论

  • 姑息性放疗可改善生活质量。
  • 在疼痛性骨转移患者中,SBRT与cRT对患者报告的生活质量结局具有相当的效果。
  • cRT组的功能干扰和心理社会方面评分改善优于接受SBRT的患者。

研究设计与样本

  • 研究为PRESENT试验的预设二次分析,基于2期随机对照VERTICAL试验(NCT02364115),采用「队列内试验」设计,共纳入110例患者,1:1随机分配至cRT或SBRT。
  • 采用欧洲癌症研究与治疗组织生活质量问卷(QLQ)核心15姑息治疗模块和QLQ骨转移22模块评估患者报告的总体生活质量、躯体功能、情绪功能、功能干扰和心理社会方面。
  • 采用意向性治疗(ITT)和符合方案集(PP)线性混合模型分析比较两组生活质量领域随时间的变化,并校正基线评分;采用χ2检验比较3个月内报告临床相关生活质量变化的患者比例。

主要发现

  • 在ITT和PP分析中,除ITT分析中的功能干扰和心理社会方面外,两组所有领域的生活质量评分随时间改善且组间相当。
  • cRT组在12周时功能干扰评分改善优于SBRT组(25.5 vs 14.1分;效应量[ES]=0.49,P=.04)。
  • cRT组在8周时心理社会方面评分改善优于SBRT组(12.2 vs 7.3分;ES=0.56,P=.04)。
  • 12周时两组在总体生活质量、躯体功能、情绪功能、功能干扰和心理社会方面未见临床相关差异。

关键数值与推荐

  • cRT组12周功能干扰评分改善25.5分 vs SBRT组14.1分(ES=0.49,P=.04)。
  • cRT组8周心理社会方面评分改善12.2分 vs SBRT组7.3分(ES=0.56,P=.04)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Painful bone metastases hamper quality of life (QoL). The aim of this prespecified secondary analysis of the PRESENT trial was to compare change in global QoL, physical functioning, emotional functioning, functional interference, and psychosocial aspects after conventional radiation therapy (cRT) versus stereotactic body RT (SBRT). METHODS AND MATERIALS: A total of 110 patients were enrolled in the phase 2 randomized controlled VERTICAL trial (NCT02364115) following the "trials within cohorts" design and randomized 1:1 to cRT or SBRT. Patient-reported global QoL, physical functioning, emotional functioning, functional interference, and psychosocial aspects were assessed by the European Organization for Research and Treatment of Cancer QoL Questionnaire (QLQ) Core 15 Palliative Care and QLQ Bone Metastases 22 modules. Changes in QoL domains over time were compared between patients treated with cRT and SBRT using intention-to-treat (ITT) and per-protocol (PP) linear mixed model analysis adjusting for baseline scores. Proportions of patients in the cRT versus SBRT arm reporting a clinically relevant change in QoL within 3 months were compared using a χ2 test. RESULTS: QoL scores had improved over time and were comparable between groups for all domains in both the ITT and PP analyses, except for functional interference and psychological aspects in the ITT. Functional interference scores had improved more after 12 weeks in the cRT arm than in the SBRT arm (25.5 vs 14.1 points, respectively; effect size [ES] = 0.49, P = .04). Psychosocial aspects scores had improved more after 8 weeks in the cRT arm than in the SBRT arm (12.2 vs 7.3; ES = 0.56, P = .04). No clinically relevant differences between groups at 12 weeks in terms of global QoL, physical functioning, emotional functioning, functional interference, and psychosocial aspects were observed. CONCLUSIONS: Palliative RT improves QoL. Both SBRT and cRT have a comparable effect on patient-reported QoL outcomes in patients with painful bone metastases. Functional interference and psychological aspects scores improved more in patients treated with cRT versus patients offered SBRT.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Pielkenrood BJ, Gal R, Kasperts N, et al. Quality of Life After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases. Int J Radiat Oncol Biol Phys. 2022. PMID: 35017007. doi:10.1016/j.ijrobp.2021.12.163

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。